Clinical and genetic characteristics of children with acute lymphoblastic leukemia and Li–Fraumeni syndrome
2021 · Leukemia · 39 citations
https://doi.org/10.1038/s41375-021-01163-y
A
Adela Escudero
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
77
Papers
826
Citations
17
h-index
19
i10-index
Adela Escudero is an academic researcher from Hospital Universitario La Paz. The author has contributed to research in topics: Immune Cell Function and Interaction & CAR-T cell therapy research & Cancer Immunotherapy and Biomarkers. The author has an h-index of 17, co-authored 66 publications.
ORCID: 0000-0001-8101-4014Papers by this author
worksOptimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy
2021 · Cancers · 30 citations
https://doi.org/10.3390/cancers13030577
Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia
2021 · Clinical Lymphoma Myeloma & Leukemia · 18 citations
https://doi.org/10.1016/j.clml.2021.01.013
Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia
2020 · BMJ Open · 14 citations
https://doi.org/10.1136/bmjopen-2019-029642
Periosteal Ewing Sarcoma with Distant Metastases: Report of Two Patients and Review of the Literature
2024 · International Journal of Surgical Pathology · 1 citations
https://doi.org/10.1177/10668969241246473
Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicity
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.14161995
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat